セフォキシチンは,クレアチニンのレベルを誤って上昇させます
関連する実験動画
Updated: Aug 12, 2026

09:09
Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
JAMA
|January 8, 1982
まとめ
セフォキシチンナトリウムは,クレアチニン検査に干渉し,血清クレアチニンの値が誤って上昇する原因となります. これは,特に重度の腎機能不全の患者の腎機能評価に影響します.
科学分野:
- 臨床化学 臨床化学について
- 薬理学 薬理学とは
- ネフロロジーはネフロロジーを用います.
背景:
- セフォキシチンナトリウム (Cefoxitin sodium) は,病院で一般的に使用される抗生物質です.
- クレアチニン測定は,腎臓機能を評価するための標準的な診断ツールです.
- 薬剤が実験室検査に潜在的に干渉すると,誤診につながる可能性があります.
研究 の 目的:
- セフォキシチンナトリウムの血清クレアチニン測定に対する効果を調査する.
- セフォキシチンを投与している患者におけるクレアチニン検査の信頼性を判断する.
主な方法:
- クレアチニン測定に対するセフォキシチンの影響を評価するためのインビトロ実験.
- ヒトボランティア研究から得られた公表されたデータの分析.
- 腎機能と注射後の時間に基づくクレアチニン検査の信頼性の評価.
主要な成果:
- セフォキシチンナトリウムは,血清クレアチニンの濃度が,投与量に依存して,明らかに上昇する原因となります.
- 観察された増加は,正常の血清クレアチニンの1.5倍から8.5倍以上であった.
- 尿中のクレアチニン測定でも同様の干渉が認められ,クレアチニンクリアランスの推定に影響を与えた.
結論:
- セフォキシチンナトリウムは,一般的なクレアチニン測定に著しく干渉する.
- 血清クレアチニン検査は,セフォキシチンを投与している重度の腎不全の患者では信頼できない.
- 検査のタイミングは,正常または軽度から中等度の腎機能を有する患者の信頼性にとって極めて重要です.
関連する概念動画
Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.

